← Leaderboards
Chang-Il Hwang
Cold Spring Harbor Laboratory
$2,406,941
Attributed
$2,406,941
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $355.3K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,406,941 · 3
By mechanism
R37$1,741,851 · 1
K22$486,000 · 1
F32$179,090 · 1
Top collaborators
No co-investigators on record.
Most similar at Cold Spring Harbor Laboratory
Same institution · by research overlap
- Terri I. Grodzicker$14,352,188
- David J. Stewart$21,230,001
- Christopher Vakoc$22,318,597
- Lindsey A Baker$159,386
- Terri I Grodzicker$1,704,393
Others in their field
Top investigators on “Organoids”
- Calvin J Kuo · Stanford University$28,394,364
- Tariq M Rana · Univ Of Med/Dent Nj-R W Johnson Med Sch$19,406,953
- Flora M Vaccarino · Yale University$18,629,201
- Alysson R. Muotri · University Of California, San Diego$18,348,745
- Sergiu Pasca · Stanford University$16,661,431
- Paola Arlotta · Massachusetts General Hospital$15,611,541
Research focus
OrganoidsPropertyPathway InteractionsGenetically Engineered MousePancreasUnited StatesPancreatic Ductal AdenocarcinomaMolecularMalignant Neoplasm Of PancreasMalignant NeoplasmsResistancePlayDisease ProgressionCancer CellMouse ModelPancreatic Cancer CellsIn VivoIn VitroTumor ProgressionResponseTranscription FactorTransplant ModelNeoplasm MetastasisGenes
Grant awards (11)
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer$354,974
R37 · FY2025 · CA · contact PI
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer$337,341
R37 · FY2024 · CA · contact PI
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer$348,109
R37 · FY2023 · CA · contact PI
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer$355,328
R37 · FY2022 · CA · contact PI
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer$346,099
R37 · FY2021 · CA · contact PI
Identification of Key Regulators in Pancreatic Cancer Metastasis$162,000
K22 · FY2020 · CA · contact PI
Identification of Key Regulators in Pancreatic Cancer Metastasis$162,000
K22 · FY2019 · CA · contact PI
Identification of Key Regulators in Pancreatic Cancer Metastasis$162,000
K22 · FY2018 · CA · contact PI
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer$63,078
F32 · FY2017 · CA · contact PI
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer$59,970
F32 · FY2016 · CA · contact PI
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer$56,042
F32 · FY2015 · CA · contact PI